This Post Was Syndicated Under License Via QuoteMedia
TORONTO, Oct. 7, 2019 /PRNewswire/ – Canopy Rivers Inc. (the “Canopy Rivers“) (TSX: RIV, OTC: CNPOF) today announced that its portfolio company, TerrAscend Corp. (“TerrAscend“) (CSE: TER, OTCQX: TRSSF) has received approval from Health Canada for a significant expansion at its Mississauga, Ontario facility. TerrAscend expects that this milestone will help the company meet the increased consumer demand for premium cannabis products and brands coming with the next wave of Canadian cannabis legalization. As the first and only cannabis company with sales in Canada, the U.S., and Europe, TerrAscend has also earmarked the additional capacity to further serve the global markets where it operates.
With this approval, TerrAscend’s licensed space nearly triples to 51,800 sq. ft. and includes additional cultivation capacity, a commercial kitchen, formulation rooms and increased primary and secondary packaging capacity. First licensed for cultivation in July 2017, TerrAscend’s 67,300 sq. ft. EU GMP certified indoor cannabis facility is focused on serving the Canadian medical and adult-use markets, conducting research & development for plant sciences and formulations, and serving as a platform for export of cannabis products to Europe and other international jurisdictions.
Canopy Rivers, along with Canopy Growth Corporation, first invested in TerrAscend in November 2017. In October 2018, both parties restructured their investment in TerrAscend. This restructuring enabled TerrAscend to pursue strategic international transactions in the cannabis space while ensuring all parties remained compliant with industry and securities regulations. More recently, Canopy Rivers announced an additional US $10 million investment in TerrAscend Canada Inc., a subsidiary of TerrAscend, cementing Canopy Rivers’ position that TerrAscend is an industry leader and a critical partner in the Canopy Rivers ecosystem.
About Canopy Rivers
Canopy Rivers is a venture capital firm specializing in cannabis. Its unique investment and operating platform is structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem.
This news release contains statements which constitute “forward-looking information” within the meaning of applicable securities laws, including statements regarding the plans, intentions, beliefs and current expectations of Canopy Rivers with respect to future business activities and operating performance. Forward-looking information is often identified by the words “may”, “would”, “could”, “should”, “will”, “intend”, “plan”, “anticipate”, “believe”, “estimate”, “expect” or similar expressions and includes information regarding: the impact of the Health Canada approval on TerrAscend’s production capacity; TerrAscend meeting increased consumer demand for cannabis products globally; the growth of consumer demand with the next wave of Canadian cannabis legalization; TerrAscend’s focus for its indoor facility; management’s view of TerrAscend’s position and partnership in the Canopy Rivers ecosystem; and expectations for other economic, business, and/or competitive factors.
Investors are cautioned that forward-looking information is not based on historical fact but instead reflects management’s expectations, estimates or projections concerning future results or events based on the opinions, assumptions and estimates of management considered reasonable at the date the statements are made. Although Canopy Rivers believes that the expectations reflected in such forward-looking information are reasonable, such information involves risks and uncertainties, and undue reliance should not be placed on such information, as unknown or unpredictable factors could have material adverse effects on future results, performance or achievements of Canopy Rivers. Among the key factors that could cause actual results to differ materially from those projected in the forward-looking information are the following: regulatory and licensing risks; the actual impact of the Health Canada approval on TerrAscend’s production capacity and the use of its space; changes in consumer demands and TerrAscend’s ability to meet such demands globally, including with the next wave of cannabis legalization; changes in general economic, business and political conditions, including changes in the financial markets; the global regulatory landscape and enforcement related to cannabis, including political risks and risks relating to regulatory change; risks relating to anti-money laundering laws; compliance with extensive government regulation; public opinion and perception of the cannabis industry; and the risk factors set out in Canopy Rivers’ annual information form dated July 15, 2019, filed with the Canadian securities regulators and available on Canopy Rivers’ profile on SEDAR at www.sedar.com.
Should one or more of these risks or uncertainties materialize, or should assumptions underlying the forward-looking information prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected. Although Canopy Rivers has attempted to identify important risks, uncertainties and factors that could cause actual results to differ materially, there may be others that cause results not to be as anticipated, estimated or intended. Canopy Rivers does not intend, and does not assume any obligation, to update this forward-looking information except as otherwise required by applicable law.
View original content to download multimedia:http://www.prnewswire.com/news-releases/canopy-rivers-portfolio-company-announces-significant-increase-in-health-canada-licensed-infrastructure-300933216.html
SOURCE Canopy Rivers Inc.